Am J Clin Oncol

1. OHAEGBULAM KC, Post CM, Farris PE, Garzotto M, et al
   Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
   Am J Clin Oncol. 2024 Oct 30. doi: 10.1097/COC.0000000000001151.
   

   >> Share

   
   

   
   BJU Int

2. DE ANGELIS M, Siech C, Di Bello F, Rodriguez Penaranda N, et al
   Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer.
   BJU Int. 2024 Oct 27. doi: 10.1111/bju.16571.
   

   >> Share

   
   

   
   BMC Cancer

3. SHAO YJ, Liao CS, Hsu YC, Chiu YC, et al
   Clinical relevance of protein-truncating variants of germline DNA repair genes in prostate cancer.
   BMC Cancer. 2024;24:1319.
   

   >> Share

   
   

   
   Eur Radiol

4. VAN LOHUIZEN Q, Roest C, Simonis FFJ, Fransen SJ, et al
   Assessing deep learning reconstruction for faster prostate MRI: visual vs. diagnostic performance metrics.
   Eur Radiol. 2024;34:7364-7372.
   

   >> Share

   
   
5. PONSIGLIONE A, Brembilla G, Cuocolo R, Gutierrez P, et al
   ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESUR.
   Eur Radiol. 2024;34:7481-7491.
   

   >> Share

   
   
6. DE ROOIJ M, Allen C, Twilt JJ, Thijssen LCP, et al
   PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI.
   Eur Radiol. 2024;34:7068-7079.
   

   >> Share

   
   

   
   Eur Urol

7. OH WK, Agarwal N, Bryce A, Barata P, et al
   What's in a Name? Why Words Matter in Advanced Prostate Cancer.
   Eur Urol. 2024 Oct 28:S0302-2838(24)02680-0. doi: 10.1016/j.eururo.2024.
   

   >> Share

   
   
8. TOUIJER KA, Vertosick EA, Sjoberg DD, Liso N, et al
   Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.
   Eur Urol. 2024 Oct 28:S0302-2838(24)02647-2. doi: 10.1016/j.eururo.2024.
   

   >> Share

   
   

   
   Int J Urol

9. OBINATA D, Yamada Y, Sumiyoshi T, Tanegashima T, et al
   Recent advances in basic research on prostate cancer: Where we are heading?
   Int J Urol. 2024 Oct 30. doi: 10.1111/iju.15628.
   

   >> Share

   
   

   
   J Nucl Med

10. SONNI I, Weiner AB, Doddipalli S, Deol M, et al
    Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI.
    J Nucl Med. 2024 Oct 30:jnumed.124.268443. doi: 10.2967/jnumed.124.268443.
    

    >> Share

    
    
11. HUANG RR, Zuo C, Mona CE, Holzgreve A, et al
    FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study.
    J Nucl Med. 2024 Oct 30:jnumed.124.268037. doi: 10.2967/jnumed.124.268037.
    

    >> Share

    
    
12. SWIHA M, Pathmanandavel S, Papa N, Sabahi Z, et al
    Comparison of Posttherapy 4- and 24-Hour [(177)Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer.
    J Nucl Med. 2024 Oct 30:jnumed.124.267606. doi: 10.2967/jnumed.124.267606.
    

    >> Share

    
    
13. MUNIZ M, Sartor O, Orme JJ, Koch RM, et al
    Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [(177)Lu]Lu-PSMA-617.
    J Nucl Med. 2024 Oct 30:jnumed.124.268277. doi: 10.2967/jnumed.124.268277.
    

    >> Share

    
    

    
    Magn Reson Med

14. LEE PK, Hess JJ, Gomella AA, Loening AM, et al
    A diffusion-prepared reduced FOV sequence for prostate MRI near metallic implants.
    Magn Reson Med. 2025;93:261-275.
    

    >> Share

    
    

    
    Prostate

15. WHYNE EZ, Jeon-Slaughter H, Kelly K, Dowell JE, et al
    Effects of Concurrent Administration of Spironolactone in Veterans with Metastatic Prostate Cancer Receiving Abiraterone: A Real-World Retrospective Study.
    Prostate. 2024 Oct 28. doi: 10.1002/pros.24811.
    

    >> Share

    
    
16. FINATI M, Morrison C, Stephens A, Chiarelli G, et al
    Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts.
    Prostate. 2024 Oct 28:e24803. doi: 10.1002/pros.24803.
    

    >> Share

    
    
17. WEI X, Zhao J, Nie L, Shi Y, et al
    Assessing the predictive value of intraductal carcinoma of the prostate (IDC-P) in determining abiraterone efficacy for metastatic hormone-sensitive prostate cancer (mHSPC) patients.
    Prostate. 2024 Oct 28. doi: 10.1002/pros.24809.
    

    >> Share

    
    

    
    Radiology

18. YANG DD, Lee LK, Tsui JMG, Leeman JE, et al
    AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.
    Radiology. 2024;313:e240041.
    

    >> Share

    
    

    
    Urol Int

19. JI G, Liu F, Chen Z, Peng J, et al
    Correlation of magnetic resonance imaging and computed tomography with biological factor expression and lymph node metastasis in aggressive prostate cancer.
    Urol Int. 2024 Oct 25:1-8. doi: 10.1159/000541953.
    

    >> Share

    
    

    
    Urology

20. RIVERA LOPEZ CA, Cheaib J, Singla N
    Editorial Comment on "Virtual reality as an adjunct to traditional patient counselling in patients with newly-diagnosed localized prostate cancer".
    Urology. 2024 Oct 23:S0090-4295(24)00929-4. doi: 10.1016/j.urology.2024.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share